NEI SBIR Phase II — R&D
Supports United States. small businesses scaling vision concepts into full development pathways.
The NIH National Eye Institute (NEI) SBIR Phase II program (R44) funds U.S. small businesses to execute full research and development projects in vision-related technology, building on successful Phase I feasibility results. NEI administers SBIR through its three extramural program divisions covering Retina/Glaucoma/Low Vision, Anterior Segment (Cornea, Lens, Dry Eye), and Strabismus/Amblyopia/Vis…
Vision-related R&D: retina, glaucoma, cornea, lens, low vision, amblyopia/strabismus, and related ocular/visual technologies with commercial potential.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline